At ACR, we strive to develop targeted therapies and interventions that address metabolic dysregulation. Our comprehensive research program focuses on understanding the complex mechanisms of metabolic diseases and testing innovative treatments that can improve patient outcomes and quality of life.
ACR conducts clinical trials across the full spectrum of metabolic disorders, including:
Testing cutting-edge medications including GLP-1 agonists, SGLT2 inhibitors, and other emerging drug classes.
Evaluating the impact of diet, exercise, and behavioral modifications on metabolic health.
Identifying novel biomarkers for early detection and monitoring of metabolic disorders.
Testing continuous glucose monitors, insulin delivery systems, and other medical devices.
Our metabolic research program includes:
We understand that metabolic disorders require comprehensive, personalized care. Our research team works closely with each participant to ensure they receive thorough monitoring, education about their condition, and support throughout the study period. Many of our studies offer participants access to the latest treatments and close medical supervision at no cost.
By participating in metabolic disorder research at ACR, you're contributing to the development of new treatments that could help millions of people worldwide manage their conditions more effectively. Your participation helps advance our understanding of metabolic diseases and brings us closer to finding better solutions for prevention, treatment, and potentially even cures.